| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |